Free Trial

Elevance Health (ELV) Stock Price, News & Analysis

$527.54
+13.51 (+2.63%)
(As of 07/26/2024 ET)
Today's Range
$516.33
$534.22
50-Day Range
$500.12
$553.08
52-Week Range
$431.38
$555.35
Volume
1.43 million shs
Average Volume
1.07 million shs
Market Capitalization
$122.33 billion
P/E Ratio
19.94
Dividend Yield
1.24%
Price Target
$604.29

Elevance Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
14.5% Upside
$604.29 Price Target
Short Interest
Healthy
0.76% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.34mentions of Elevance Health in the last 14 days
Based on 39 Articles This Week
Insider Trading
Selling Shares
$17.19 M Sold Last Quarter
Proj. Earnings Growth
11.89%
From $37.25 to $41.68 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.74 out of 5 stars

Medical Sector

56th out of 936 stocks

Hospital & Medical Service Plans Industry

5th out of 11 stocks

ELV stock logo

About Elevance Health Stock (NYSE:ELV)

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

ELV Stock Price History

ELV Stock News Headlines

Doctor in glasses looking at diagnosis on clipboard, african american woman, private ward — Photo
Leading Healthcare Provider Stock Soars on Earnings Beat (ELV)
Molina Healthcare's Q2 earnings and strategic acquisitions fuel a surge in its stock price, signaling the potential for continued growth.
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.
African american woman meeting with medic on videocall, attending telemedicine videoconference with webcam to discuss about healthcare and treatment. Online telehealth conference.
Is This Telehealth Stock a Buy After the Recent Pullback? (ELV)
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.
Elevance Health (NYSE:ELV) PT Lowered to $589.00
See More Headlines
Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/25 Dividend
6/10/2024
Dividend Payable
6/25/2024
Last Earnings
7/17/2024
Today
7/26/2024
Next Earnings (Estimated)
10/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
CUSIP
94973V10
Employees
104,900
Year Founded
2004

Price Target and Rating

Average Stock Price Target
$604.29
High Stock Price Target
$649.00
Low Stock Price Target
$530.00
Potential Upside/Downside
+13.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
15 Analysts

Profitability

Net Income
$5.99 billion
Pretax Margin
4.99%

Debt

Sales & Book Value

Annual Sales
$171.34 billion
Cash Flow
$42.90 per share
Book Value
$182.40 per share

Miscellaneous

Free Float
231,605,000
Market Cap
$123.55 billion
Optionable
Optionable
Beta
0.84

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Ms. Gail Koziara Boudreaux (Age 63)
    President, CEO & Director
    Comp: $6.09M
  • Mr. Mark Bradley Kaye (Age 44)
    Executive VP & CFO
    Comp: $659.18k
  • Mr. Blair Williams Todt (Age 56)
    EVP, Chief Legal & Administrative Officer
    Comp: $2.11M
  • Mr. Peter David Haytaian Esq. (Age 54)
    Executive VP and President of Carelon & CarelonRx
    Comp: $2.68M
  • Ms. Felicia Farr NorwoodMs. Felicia Farr Norwood (Age 64)
    Executive VP & President of Government Health Benefits
    Comp: $2.18M
  • Mr. Scott Wayne Anglin
    SVP, Treasurer & Chief Investment Officer
  • Mr. Ronald William Penczek (Age 59)
    Senior VP, Controller & Chief Accounting Officer
  • Mr. Anil Bhatt
    Chief Information Officer
  • Mr. Stephen Vartan Tanal C.F.A.
    Vice President of Investor Relations
  • Ms. Julie Goon
    Senior Vice President of Public Affairs

ELV Stock Analysis - Frequently Asked Questions

How have ELV shares performed this year?

Elevance Health's stock was trading at $471.56 at the beginning of 2024. Since then, ELV shares have increased by 11.9% and is now trading at $527.54.
View the best growth stocks for 2024 here
.

How were Elevance Health's earnings last quarter?

Elevance Health, Inc. (NYSE:ELV) posted its earnings results on Wednesday, July, 17th. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.99 by $0.13. Elevance Health's quarterly revenue was down .4% on a year-over-year basis.

Does Elevance Health have any subsidiaries?

Elevance Health subsidiaries include Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and more.

Who are Elevance Health's major shareholders?

Elevance Health's top institutional shareholders include Baillie Gifford & Co. (1.24%), Bank of New York Mellon Corp (0.72%), Ninety One UK Ltd (0.38%) and Sumitomo Mitsui Trust Holdings Inc. (0.35%). Insiders that own company stock include Gail Boudreaux, Gloria M Mccarthy, Felicia F Norwood, Charles Morgan Kendrick Jr, Robert L Dixon Jr, Ramiro G Peru, Ronald W Penczek and Peter D Haytaian.
View institutional ownership trends
.

How do I buy shares of Elevance Health?

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ELV) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners